Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Abstract Although new developments of surgery, chemotherapy, radiotherapy, and immunotherapy treatments for cancer have improved patient survival, the emergence of chemoresistance in cancer has significant impacts on treatment effects. The development of chemoresistance involves several polygenic, p...
Main Authors: | Guo-Hua Li, Qiang Qu, Ting-Ting Qi, Xin-Qi Teng, Hai-Hong Zhu, Jiao-Jiao Wang, Qiong Lu, Jian Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-01974-y |
Similar Items
-
Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
by: Xun Chen, et al.
Published: (2020-07-01) -
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
by: Dimas Carolina Belisario, et al.
Published: (2020-12-01) -
Editorial: Interplay between epigenetic modifiers and transcription factors in driving cancer progression
by: Yongyong Yang, et al.
Published: (2023-06-01) -
The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
by: QingYi Zhao, et al.
Published: (2022-06-01) -
Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer
by: Zhen-Chu Tang, et al.
Published: (2023-07-01)